AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by “bombarding” smaller companies with litigation it knows they won’t be able to afford — a claim that medical IP lawyers have backed up.
A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Innovative approaches to real world evidence collection present opportunities for medical device companies to improve patient outcomes. But success will depend on improving the way medtech companies integrate digital health. Executives from Abbott, Smith & Nephew, AliveCor and Huma weigh in on these issues.
With its two major announcements at the Global Health Conference & Exhibition in Orlando, the company signaled it is aiming to help providers access more in-depth, real-time patient data to improve clinical decision-making and care.
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can lead to QT prolongation, which can increase the risk of certain arrhythmias.
The digital health company filed a complaint with the Federal Trade Commission last week, seeking a ban on the import of the Apple Watch. AliveCor cited copyright violations related to Apple’s ECG feature as the reason for seeking the ban.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.
The startup, which has developed a portable ECG device, received clearance for algorithms to detect more cardiac conditions, such as premature contractions.
MedCity News caught up with Omron Healthcare CEO Ranndy Kellogg at the the AdvaMed Digital MedTech Conference in San Francisco to speak about the company's new products, emerging business lines and how collaboration with other companies have driven recent innovation.
The Microsoft co-founder and billionaire philanthropist's choices for the healthcare innovations that have the potential to change the world range from personalized cancer vaccines to voice assistants.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The pre-order price of the device is $499 and it will be available in retail stores starting in January.
AliveCor's Kardiaband is designed to help consumers manage the task of detecting Afib, a form of heart arrhythmia and will help Apple bolster its relevance to healthcare.
Although Long QT syndrome can be inherited and acquired, the inherited version of the condition can leave up to 160,000 vulnerable to the disease.
Here are some highlights from the 50+ Innovation Leaders eBook highlighting CEOs across smart living and wearables, healthcare delivery, medication management, entrepreneurial innovation and behavioral health.
Remote monitoring was a dominant theme among digital health companies closing funding rounds this week.